NCT03006471View on ClinicalTrials.gov

Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 30, 2016

Primary Completion Date

March 30, 2018

Study Completion Date

June 29, 2018

Conditions
PreDiabetesPrehypertension
Interventions
DRUG

Dapagliflozin

10 mg, one per day before breakfast during 12 weeks.

DRUG

Placebo - Cap

one per day before breakfast during 12 weeks.

Trial Locations (1)

44340

Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT03006471 - Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension | Biotech Hunter | Biotech Hunter